Browse > Article

The Effect of Thymoma on Remission for Patients Who Undergo Thymectomy for Myasthenia Gravis  

Kim, Hee-Jung (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine)
Park, Seung-Il (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine)
Kang, Seong-Sik (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Eulji University)
Lee, Eung-Sirk (Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University)
Kim, Yong-Hee (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine)
Bae, Chi-Hoon (Department of Thoracic & Cardiovascular Surgery, School of Medicine, Catholic University of Daegu)
Kim, Dong-Kwan (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine)
Publication Information
Journal of Chest Surgery / v.40, no.11, 2007 , pp. 759-764 More about this Journal
Abstract
Background: Thymoma occurs in approximately 10% of myasthnia gravis patients. The thymus or a thymoma plays a role in the pathogenesis of myasthenia gravis. However, there is currently no definitive position about the effect of thymectomy on patients' symptoms and prognosis. We retrospectively studied the effect of thymoma on re-mission in patients who underwent thymectomy for myasthenia gravis. Material and Method: From July, 1992 to December, 2002, we performed extended thymectomy due to myasthenia gravis for 100 patients. The thymoma group included 30 people, the non-thymoma group included 70 people and the change of the Ossermann stage between the two groups after surgery was compared. Result: For the non-thymoma group, the average age was 34.7 years (range: $12.7{\sim}47.7$). Before the surgical operation, the Ossermann stage for the non-thymoma group was an average of 3.00, and this was reduced to an average of 1.41 after operation. For the thymoma group, the average age was 50.9 years (range: $37.3{\sim}64.5$). Before the surgical operation, the Ossermann stage for the thymoma group was an average of 3.00, and this was reduced to an average of 1.47 after operation. The non-thymoma patients had a higher proportion of males than the thymoma patients (35% vs 30%, respectively), The Masaoka stage was stage of the thymoma group was I for 27 patients and stage II for 3 patients. There was no statistically significant Ossermann stage change between the thymoma and non-thymoma groups. Conclusion: Whether thymoma was present or not, there was no significant difference on remission and improvement of myasthenia symptoms after thymectomy in the myasthenia gravis patients.
Keywords
Thymoma; Myasthenia gravis; Thymectomy;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Sanders DB, Scoppetta C. The treatment of patients with myasthenia gravis. Neurol Clin North Am 1994;12:343-68   DOI
2 Weigert C. Pathologisch-anatomischer Beitrag zur Erbschen Krankheit (Myasthenia gravis). Neurol Zentralbl 1901;20:597-601
3 Blalock A, Mason MF, Morgan HJ, Riven SS. Myasthenia gravis and tumors of the thymic region: report of a case in which tumor was removed. Ann Surg 1939;110: 554-61
4 Perrot M, Liu J, Bril V, McRae K, Bezjak A, Keshavjee, SH. Prognostic significance of thymomas in patiens with myasthenia gravis. Ann Thorac Surg 2002;74:1658-62   DOI   ScienceOn
5 Budde JM, Morris CD, Gal AA, Mansour KA, Miller JI Jr. Predictors of outcome in thymectomy for myasthenia gravis. Ann Thorac Surg 2001;72:197-202   DOI   ScienceOn
6 Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol 1999;17:2280-9   DOI   PUBMED
7 Masaoka A, Yamakawa Y, Niwa H, et al. Extended thymectomy for myasthenia gravis patients: a 20-year review. Ann Thorac Surg 1996;62:853-9   DOI   ScienceOn
8 Monden Y, Nakahara K, Nanjo S, et al. Invasive thymoma with myasthenia gravis. Cancer 1984;54:2513-8   DOI   ScienceOn
9 Bril V, Kojic C, Ilse WK, Cooper JD. Long-term Clinical outcome after transcervical thymectomy for myasthenia gravis. Ann Thorac Surg 1998;65:1520-2   DOI   ScienceOn
10 Vincent A, Wilcox N, Hill M, Curnow J, MacLennan C, Beeson D. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis. Immunol Rev 1998;164:157-68   DOI   ScienceOn
11 Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 2001;357:2122-8   DOI   ScienceOn
12 Berrih-Akin S, Morel E, Raimond F. The role of the thymus in myasthenia gravis immunohistological and immunological studies in 115 case. Ann N Y Acad Sci 1987;505:51-70
13 Wakata N, Fujoka T, Nishina M, Kawamura Y, Kobayashi M, Kinoshia M. Myasthenia gravis and invasive thymoma. Eur Neurol 1993;33:115-20   DOI   ScienceOn
14 KIM DK, Kang SS, Chun MS, et al. Prognostic relevance of WHO classification and masaoka stage in thymoma. Korean J Thorac Cardiovasc Surg 2005;38:44-9   과학기술학회마을